137 related articles for article (PubMed ID: 34607194)
1. Do people with opioid use disorder and posttraumatic stress disorder benefit from dding Individual opioid Drug Counseling to buprenorphine?
McHugh RK; Hilton BT; Chase AM; Griffin ML; Weiss RD
Drug Alcohol Depend; 2021 Nov; 228():109084. PubMed ID: 34607194
[TBL] [Abstract][Full Text] [Related]
2. Posttraumatic stress disorder in individuals seeking treatment for opioid use disorder in Vermont.
Peck KR; Moxley-Kelly N; Badger GJ; Sigmon SC
Prev Med; 2021 Nov; 152(Pt 2):106817. PubMed ID: 34599919
[TBL] [Abstract][Full Text] [Related]
3. Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder.
Seal KH; Maguen S; Bertenthal D; Batki SL; Striebel J; Stein MB; Madden E; Neylan TC
J Clin Psychiatry; 2016 Sep; 77(9):1182-1188. PubMed ID: 27035058
[TBL] [Abstract][Full Text] [Related]
4. Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
Shulman M; Weiss R; Rotrosen J; Novo P; Costello E; Nunes EV
Addict Sci Clin Pract; 2021 Mar; 16(1):15. PubMed ID: 33676577
[TBL] [Abstract][Full Text] [Related]
5. Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder.
Meshberg-Cohen S; Black AC; DeViva JC; Petrakis IL; Rosen MI
Addict Behav; 2019 Feb; 89():29-34. PubMed ID: 30243036
[TBL] [Abstract][Full Text] [Related]
6. A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report.
Goodman DJ; Milliken CU; Theiler RN; Nordstrom BR; Akerman SC
J Dual Diagn; 2015; 11(3-4):248-57. PubMed ID: 26457976
[TBL] [Abstract][Full Text] [Related]
7. Comparison of behavioral treatment conditions in buprenorphine maintenance.
Ling W; Hillhouse M; Ang A; Jenkins J; Fahey J
Addiction; 2013 Oct; 108(10):1788-98. PubMed ID: 23734858
[TBL] [Abstract][Full Text] [Related]
8. Group-based treatment of opioid use disorder with buprenorphine: A systematic review.
Sokol R; LaVertu AE; Morrill D; Albanese C; Schuman-Olivier Z
J Subst Abuse Treat; 2018 Jan; 84():78-87. PubMed ID: 29195596
[TBL] [Abstract][Full Text] [Related]
9. Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder.
Schroeder JR; Phillips KA; Epstein DH; Jobes ML; Furnari MA; Kennedy AP; Heilig M; Preston KL
Psychopharmacology (Berl); 2018 Oct; 235(10):2957-2966. PubMed ID: 30079432
[TBL] [Abstract][Full Text] [Related]
10. Cognitive-behavioral therapy and buprenorphine for opioid use disorder: A systematic review and meta-analysis of randomized controlled trials.
Gregory VL; Ellis RJB
Am J Drug Alcohol Abuse; 2020 Sep; 46(5):520-530. PubMed ID: 32960649
[No Abstract] [Full Text] [Related]
11. Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
Tofighi B; Grossman E; Goldfeld KS; Williams AR; Rotrosen J; Lee JD
Subst Use Misuse; 2015; 50(12):1571-8. PubMed ID: 26623697
[TBL] [Abstract][Full Text] [Related]
12. Comparison of buprenorphine treatment for opioid dependence in 3 settings.
Miotto K; Hillhouse M; Donovick R; Cunningham-Rathner J; Charuvastra C; Torrington M; Esagoff AE; Ling W
J Addict Med; 2012 Mar; 6(1):68-76. PubMed ID: 22105061
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
Dunn KE; Tompkins DA; Bigelow GE; Strain EC
JAMA Psychiatry; 2017 Sep; 74(9):885-893. PubMed ID: 28700791
[TBL] [Abstract][Full Text] [Related]
14. Effects of Interim Buprenorphine Treatment for opioid use disorder among emerging adults.
Peck KR; Ochalek TA; Badger GJ; Sigmon SC
Drug Alcohol Depend; 2020 Mar; 208():107879. PubMed ID: 31991327
[TBL] [Abstract][Full Text] [Related]
15. Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.
Fiellin DA; Schottenfeld RS; Cutter CJ; Moore BA; Barry DT; O'Connor PG
JAMA Intern Med; 2014 Dec; 174(12):1947-54. PubMed ID: 25330017
[TBL] [Abstract][Full Text] [Related]
16. Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management?
Weiss RD; Griffin ML; Potter JS; Dodd DR; Dreifuss JA; Connery HS; Carroll KM
Drug Alcohol Depend; 2014 Jul; 140():118-22. PubMed ID: 24831754
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes.
Samples H; Williams AR; Crystal S; Olfson M
J Subst Abuse Treat; 2022 Aug; 139():108774. PubMed ID: 35337716
[TBL] [Abstract][Full Text] [Related]
18. Within-subject evaluation of interim buprenorphine treatment during waitlist delays.
Oleskowicz TN; Ochalek TA; Peck KR; Badger GJ; Sigmon SC
Drug Alcohol Depend; 2021 Mar; 220():108532. PubMed ID: 33508690
[TBL] [Abstract][Full Text] [Related]
19. Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder.
Greenwald MK; Wiest KL; Haight BR; Laffont CM; Zhao Y
Harm Reduct J; 2023 Dec; 20(1):173. PubMed ID: 38042801
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine for the treatment of posttraumatic stress disorder.
Lake EP; Mitchell BG; Shorter DI; Kosten T; Domingo CB; Walder AM
Am J Addict; 2019 Feb; 28(2):86-91. PubMed ID: 30664299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
